Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients

被引：18
作者：
Lentine K.L. [1 ,2 ]
Parsonnet J. [3 ,4 ]
Taylor I. [5 ]
Wrone E.M. [6 ]
Lafayette R.A. [5 ]
机构：
[1] Saint Louis University Center, Outcomes Research Salus Center, St. Louis, MO 63104
[2] Division of Nephrology, Department of Medicine, Saint Louis University School of Medicine, St. Louis, MO
[3] Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA
[4] Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA
[5] Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Stanford, CA
[6] Diablo Nephrology Medical Group, Walnut Creek, CA
来源：
Clinical and Experimental Nephrology | 2006年 / 10卷 / 1期
关键词：
C-reactive protein; Cardiovascular disease; Chlamydia pneumoniae; Helicobacter pylori; Hemodialysis; Mortality;
D O I：
10.1007/s10157-005-0392-5
中图分类号：
学科分类号：
摘要：
Background. Inflammatory markers predict cardiovascular risk and mortality in endstage renal disease. The relationship of chronic infections to inflammation and vascular disease events has not been reported among American dialysis patients. Methods. We performed a cross-sectional and prospective study of a multiracial cohort of 97 chronic hemodialysis patients in California. Anti-Chlamydia pneumoniae IgA and IgG antibodies (Cp-IgA and Cp-IgG), anti-Helicobacter pylori antibodies (Hp-IgG), and highly sensitive C-reactive protein (hsCRP) levels were measured at enrollment. We ascertained the prevalence of atherosclerotic vascular (coronary artery, cerebrovascular, and peripheral vascular) disease (AVD) events, and observed participants for at least 1 year for incident events and mortality. We defined statistical significance as P < 0.01. Results. Elevated hsCRP levels (77%) and seropositivity to C. pneumoniae were common (Cp-IgA, 49%; Cp-IgG, 64%), whereas the seroprevalence of Hp-IgG was relatively low (25%). The hsCRP levels did not vary with infection status. In bivariate analysis, Cp-IgA and Cp-IgG were each associated with approximately fourfold higher odds of prevalent AVD (P < 0.01). Although anti-chlamydial antibodies maintained nearly significant associations with AVD after covariate adjustment (P < 0.05), antibodies did not predict outcomes over the period of observation. However, hsCRP was a nearly significant independent predictor of prevalent AVD (P = 0.02) and of mortality during follow-up (P = 0.01). We did not detect an association of Hp-IgG with any study outcome. Conclusions. Our findings generalize a possible link between C. pneumoniae and prevalent atherosclerosis in American hemodialysis patients and confirm the importance of hsCRP as a prognostic indicator. Our work does not support H. pylori as an important mediator of cardiovascular risk in dialysis patients. © Japanese Society of Nephrology 2006.
引用
收藏
页码：55 / 62
页数：7
相关论文
共 33 条
  • [1] Stenvinkel P., Heimburger O., Paultre F., Diczfalusy U., Wang T., Berglund L., Et al., Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure, Kidney Int, 55, pp. 1899-911, (1999)
  • [2] Zimmermann J., Herrlinger S., Pruy A., Metzger T., Wanner C., Inflammation enhances cardiovascular risk and mortality in hemodialysis patients, Kidney Int, 55, pp. 648-58, (1999)
  • [3] Saikku P., Leinonen M., Mattila K., Et al., Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction, Lancet, 2, pp. 983-6, (1988)
  • [4] Kuo C.C., Coulson A.S., Campbell L.A., Cappuccio A.L., Lawrence R.D., Wang S.P., Et al., Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction, J Vasc Surg, 26, pp. 29-31, (1997)
  • [5] Moazed T.C., Campbell L.A., Rosenfeld M.E., Grayston J.T., Kuo C.C., Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice, J Infect Dis, 180, pp. 238-41, (1999)
  • [6] Danesh J., Youngman L., Clark S., Parish S., Peto R., Collins R., Helicobacter pylori infection and early onset myocardial infarction: Case-control and sibling pairs study, BMJ, 319, pp. 1157-62, (1999)
  • [7] Zoccali C., Benedetto F.A., Mallamaci F., Tripepi G., Fermo I., Foca A., Et al., Inflammation is associated with carotid atherosclerosis in dialysis patients. CREED Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients, J Hypertens, 18, pp. 1207-13, (2000)
  • [8] Stenvinkel P., Heimburger O., Jogestrand T., Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity, Am J Kidney Dis, 39, pp. 274-82, (2002)
  • [9] Zoccali C., CREED Investigators. C-reactive protein and atherosclerosis in dialysis patients, Nephrol Dial Transplant, 13, pp. 2710-1, (1998)
  • [10] Haubitz M., Brunkhorst R., C-reactive protein and chronic Chlamydia pneumoniae infection - Long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis, Nephrol Dial Transplant, 16, pp. 809-15, (2001)
1234